Tisch MS News

Record-Breaking Totals: 2023 Future Without MS Gala

We are thrilled to share the incredible success of our 2023 Future Without MS Gala . With unwavering dedication and support from our donor community, this event shattered all previous records, raising 4.4 million dollars . The outpouring of generosity from individuals and organizations alike is...

October 26, 2023

More

Researchers Attend MS Milan 2023

Last week, our scientist attended #MSMilan2023. The event was jointly hosted by #Ectrims & #Actrims and gathered MS experts from across the globe to meet and discuss some of the groundbreaking MS news and research. Our team shared and present 5 different topics: PAK1 and E2F1 dysregulation...

October 18, 2023

More

Junior Investigator of the Year-Anjali Kumar

Congratulations to Tisch MSRCNY's 2023 Junior Investigator of the Year, Anjali Kumar, for her outstanding performance as the Best Junior Scientist! Anjali is the clinical research assistant, working with the clinical team and Dr. Sadiq on the Phase 2 stem cell trial. She plays a role in assessing...

October 4, 2023

More

Journal Club 9/22/23

Last week, our researchers and physicians discussed a paper regarding the association of higher Ocrelizumab exposure with reduced disability progression in MS. Ocrelizumab, or Ocrevus, is a prescription drug commonly used to treat both progressive and relapsing-remitting MS. Ocrelizumab was shown...

September 25, 2023

More

9/8 Journal Club

Last week our researchers and physicians discussed a paper about bile acid metabolites, and their implications in MS research. Bile acid metabolites are signaling molecules that work throughout the central nervous system, and researchers identified lower levels of these metabolites in MS patients...

September 11, 2023

More

Featured in Interesting Engineering

Dr. Nicolas Daviaud was recently interviewed by the team at Interesting Engineering. We are excited to share the piece, which highlights Dr. Daviaud's work with cerebral organoids! Click here to read the full article online. Click here to read the full PDF version.

September 7, 2023

More

Labor Day

In observance of Labor Day, Tisch MSRCNY will close at 1:00 PM today and reopen on Tuesday, September 5th. We wish everyone a safe and happy holiday!

September 1, 2023

More

Dr. Nicolas Daviaud's Interview with RegMedNet

Advancing multiple sclerosis with cerebral organoids: an interview with Nicolas Daviaud With this year marking ten years since the development of cerebral organoids, we spoke to Nicolas Daviaud to learn how the Tisch Multiple Sclerosis Research Center of New York (USA) is using them as a model for...

August 17, 2023

More

Featured in The New Yorker!

We’re excited to share that our Center was featured in an article in The New Yorker! Drawing from interviews with some of our patients, our Principal Investigators, and Dr. Sadiq, the piece highlights how our comprehensive approach to MS research has led to some of the most significant recent...

July 17, 2023

More

MS News Today Feature

Results, however, indicated that MSC-NP improved walking ability for people with more advanced disease — those who need an aid to walk short distances. Patients treated with MSC-NP also often reported fewer bladder problems following treatment. “The findings of this study suggest that stem cells...

June 19, 2023

More

Pages

News Archive

Pages

More »

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.